Stryker (SYK) Liabilities and Shareholders Equity (2009 - 2026)
Stryker (SYK) reported Liabilities and Shareholders Equity of $46.3 billion for Q1 2026, up 0.62% year-over-year from $46.0 billion in Q1 2025, and down 3.25% on a QoQ basis from $47.8 billion in Q4 2025.
Stryker (SYK) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $46.3 billion in Q1 2026.
- Quarterly Liabilities and Shareholders Equity rose 0.62% year-over-year to $46.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $187.5 billion (up 9.06% YoY) and the FY2025 annual result came in at $47.8 billion, up 11.34% from the prior year.
- Liabilities and Shareholders Equity fell to $46.3 billion in Q1 2026 per SYK's latest filing, from $47.8 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $47.8 billion in Q4 2025 and bottomed at $36.0 billion in Q3 2022.
- The 5-year median for Liabilities and Shareholders Equity is $39.4 billion (2024), against an average of $40.9 billion.
- The widest annual swing landed in 2025, when Liabilities and Shareholders Equity increased 18.4%; it then advanced 0.62% in 2026.
- Tracing SYK's Liabilities and Shareholders Equity over 5 years: stood at $36.9 billion in 2022, then gained by 8.21% to $39.9 billion in 2023, then rose by 7.66% to $43.0 billion in 2024, then increased by 11.34% to $47.8 billion in 2025, then slipped by 3.25% to $46.3 billion in 2026.
- Per Business Quant, the three latest SYK Liabilities and Shareholders Equity figures stand at $46.3 billion (Q1 2026), $47.8 billion (Q4 2025), and $47.1 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 22.72 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.29 Bn |
| Dec 31, 2025 | 47.84 Bn |
| Sep 30, 2025 | 47.06 Bn |
| Jun 30, 2025 | 46.33 Bn |
| Mar 31, 2025 | 46.01 Bn |
| Dec 31, 2024 | 42.97 Bn |
| Sep 30, 2024 | 43.83 Bn |
| Jun 30, 2024 | 39.13 Bn |
| Mar 31, 2024 | 39.40 Bn |
| Dec 31, 2023 | 39.91 Bn |
| Sep 30, 2023 | 38.04 Bn |
| Jun 30, 2023 | 37.41 Bn |
| Mar 31, 2023 | 36.83 Bn |
| Dec 31, 2022 | 36.88 Bn |
| Sep 30, 2022 | 35.98 Bn |
| Jun 30, 2022 | 36.03 Bn |
| Mar 31, 2022 | 36.14 Bn |
| Dec 31, 2021 | 34.63 Bn |
| Sep 30, 2021 | 34.15 Bn |
| Jun 30, 2021 | 33.70 Bn |
| Mar 31, 2021 | 33.46 Bn |
| Dec 31, 2020 | 34.33 Bn |
| Sep 30, 2020 | 32.29 Bn |
| Jun 30, 2020 | 31.48 Bn |
| Mar 31, 2020 | 29.44 Bn |
| Dec 31, 2019 | 30.17 Bn |
| Sep 30, 2019 | 26.66 Bn |
| Jun 30, 2019 | 26.35 Bn |
| Mar 31, 2019 | 25.94 Bn |
| Dec 31, 2018 | 27.23 Bn |
| Sep 30, 2018 | 22.08 Bn |
| Jun 30, 2018 | 21.57 Bn |
| Mar 31, 2018 | 22.13 Bn |
| Dec 31, 2017 | 22.20 Bn |
| Sep 30, 2017 | 21.49 Bn |
| Jun 30, 2017 | 21.29 Bn |
| Mar 31, 2017 | 20.52 Bn |
| Dec 31, 2016 | 20.44 Bn |
| Sep 30, 2016 | 20.19 Bn |
| Jun 30, 2016 | 20.52 Bn |
| Mar 31, 2016 | 19.67 Bn |
| Dec 31, 2015 | 16.22 Bn |
| Sep 30, 2015 | 15.92 Bn |
| Jun 30, 2015 | 16.82 Bn |
| Mar 31, 2015 | 16.58 Bn |
| Dec 31, 2014 | 17.26 Bn |
| Sep 30, 2014 | 17.52 Bn |
| Jun 30, 2014 | 17.23 Bn |
| Mar 31, 2014 | 16.16 Bn |
| Dec 31, 2013 | 15.40 Bn |
| Sep 30, 2013 | 14.88 Bn |
| Jun 30, 2013 | 14.38 Bn |
| Mar 31, 2013 | 14.09 Bn |
| Dec 31, 2012 | 13.21 Bn |
| Sep 30, 2012 | 12.78 Bn |
| Jun 30, 2012 | 12.26 Bn |
| Mar 31, 2012 | 12.46 Bn |
| Dec 31, 2011 | 12.15 Bn |
| Sep 30, 2011 | 12.08 Bn |
| Jun 30, 2011 | 11.60 Bn |
| Mar 31, 2011 | 11.23 Bn |
| Dec 31, 2010 | 10.66 Bn |
| Sep 30, 2010 | 10.77 Bn |
| Jun 30, 2010 | 10.06 Bn |
| Mar 31, 2010 | 10.10 Bn |
| Dec 31, 2009 | 9.07 Bn |
| Sep 30, 2009 | 8.46 Bn |
| Jun 30, 2009 | 7.92 Bn |